LUNA vs. BASI, PGEN, MXCT, NOTV, ONMD, BIAF, AIKI, DKDCA, ISPC, and FOXO
Should you be buying Luna Innovations stock or one of its competitors? The main competitors of Luna Innovations include Bioanalytical Systems (BASI), Precigen (PGEN), MaxCyte (MXCT), Inotiv (NOTV), OneMedNet (ONMD), bioAffinity Technologies (BIAF), AIkido Pharma (AIKI), Data Knights Acquisition (DKDCA), iSpecimen (ISPC), and FOXO Technologies (FOXO).
Bioanalytical Systems (NASDAQ:BASI) and Luna Innovations (NASDAQ:LUNA) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, community ranking, profitability, valuation, institutional ownership, risk, dividends, earnings and analyst recommendations.
Luna Innovations has a consensus price target of $10.00, indicating a potential upside of 184.09%. Given Bioanalytical Systems' higher probable upside, analysts clearly believe Luna Innovations is more favorable than Bioanalytical Systems.
10.6% of Bioanalytical Systems shares are held by institutional investors. Comparatively, 87.5% of Luna Innovations shares are held by institutional investors. 11.5% of Bioanalytical Systems shares are held by company insiders. Comparatively, 7.6% of Luna Innovations shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
In the previous week, Luna Innovations had 1 more articles in the media than Bioanalytical Systems. MarketBeat recorded 1 mentions for Luna Innovations and 0 mentions for Bioanalytical Systems. Luna Innovations' average media sentiment score of 0.00 equaled Bioanalytical Systems'average media sentiment score.
Luna Innovations received 71 more outperform votes than Bioanalytical Systems when rated by MarketBeat users. Likewise, 61.23% of users gave Luna Innovations an outperform vote while only 41.16% of users gave Bioanalytical Systems an outperform vote.
Bioanalytical Systems has a beta of 1.92, indicating that its share price is 92% more volatile than the S&P 500. Comparatively, Luna Innovations has a beta of 1.55, indicating that its share price is 55% more volatile than the S&P 500.
Luna Innovations has higher revenue and earnings than Bioanalytical Systems. Luna Innovations is trading at a lower price-to-earnings ratio than Bioanalytical Systems, indicating that it is currently the more affordable of the two stocks.
Luna Innovations has a net margin of -1.82% compared to Luna Innovations' net margin of -7.75%. Bioanalytical Systems' return on equity of 3.61% beat Luna Innovations' return on equity.
Summary
Luna Innovations beats Bioanalytical Systems on 13 of the 16 factors compared between the two stocks.
Get Luna Innovations News Delivered to You Automatically
Sign up to receive the latest news and ratings for LUNA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding LUNA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Luna Innovations Competitors List
Related Companies and Tools
